1Martin BC, Warram JH, Krolewski AS, et al. Role of glucose and insulin resistance in development of type 2 diabetes Mellitus: results of a 25-year follow-up study. Lancet, 1992,340:925-929. 被引量：1
2Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of type Ⅱ diabetes mellitus. Diabetologia,2001,44:929-945. 被引量：1
3Saad MF, Knowler WC, Pettitt DJ, et al. A two-stop model for development of non-insulin-dependent diabetes. Am J Med, 1991,90:229-235. 被引量：1
3Harris MI. Impaired glucose tolerance in the US population. Diabetes Care 1992;12:464-474. 被引量：1
4Praley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of type 2 diabetes mellitus. Diabetologia 2001 ;44 : 929 - 945. 被引量：1
5Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996 ;45 : 1661 - 1669. 被引量：1
6S. M. A. Bennett, A. Agrawal, H. Elasha, et al. Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance. 2004 Diabetes UK. Diabetic Medicine 21,415 -422.. 被引量：1
7Adukauskiene D,Blauzdyte.Cauls,diagnosis,and treatment of hypoglycemia[J].Medieina (Kaunas),2006,42(10):860-870. 被引量：1
8American Diabetes Association.Standards of medical care in diabetes-2008[J].Diabetes Care,2008,31 (Suppl 1):S112-54. 被引量：1
9Peter S.Aearbose and idiopathic reactive hypoglycemia[J].Horm Res,2003,60(4):166-169. 被引量：1
10Ozgen A G,Hamulu F,Bayraktar F,et al.Long-term treatment with acarbose for the treatment of reactive hypoglycemia[J].Eat Weight Disord,1998,3(3):136-140. 被引量：1
